The evolution of pharma customer engagement insight
Over the last three years, customer engagement in the pharmaceutical industry has evolved significantly. Despite the improvement in screen-to-screen (S2S) interactions since 2020, face-to-face (F2F) operations are still on the agenda for many pharma companies. To fully realize the potential of a fit-for-purpose engagement model, the following points should be considered:
- A blended engagement model
- Emotive, patient-centric selling
- Referencing previous HCP interactions
- Cross-functional account management
Putting this strategy into practice, a tailored engagement model can be made to achieve the best-selling outcome.
In the full article from STEM, an Inizio Advisory company, the evolution to a more integrated, hybrid and patient-centric engagement model is explored in more detail.
https://www.stemhealthcare.com/insights/the-evolution-of-pharma-customer-engagement/
Jump to a slide with the slide dots.
3 Pharmaceutical Data Strategy & Market Research Tactics to Make Confident Commercial Decisions
Pharma leaders harness data & AI for insights, but confidence requires a strong foundation. Learn why pausing can drive better decisions.
Read moreSupercharge Strategy with Targeted Innovation
Unlock the potential of data and AI with InizioNavigator.ai, combining pharma expertise and advanced tools to solve key challenges and innovation.
Read morePatient-centricity in oncology and why it’s more important than ever
While significant progress has been made in focusing on patient needs, our experts emphasize that much still needs to be done.
Read more